2018 annual financial data
Innate Pharma 2018 Operating margin
Direct answer
Operating margin was 6.44%.
Operating income was 5,146,000 EUR and net income was 3,049,000 EUR.
Operating cash flow was Not available.
Get free Innate Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 79,892,000 EUR
- Operating income
- 5,146,000 EUR
- Net income
- 3,049,000 EUR
- Operating cash flow
- Not available